SLC14A1 and metastatic prostate carcinoma: More importantly, we also found that SLC14A1 is significantly lower in PIN, prostate cancer in situ and metastatic prostate cancer compared to normal prostate by re-analyzing a large set of prostate cancer patients58 (Fig. 5B).